GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Innovation1 Biotech Inc (OTCPK:IVBT) » Definitions » Scaled Net Operating Assets

Innovation1 Biotech (Innovation1 Biotech) Scaled Net Operating Assets : -0.84 (As of Aug. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Innovation1 Biotech Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Innovation1 Biotech's operating assets for the quarter that ended in Aug. 2023 was $0.03 Mil. Innovation1 Biotech's operating liabilities for the quarter that ended in Aug. 2023 was $3.28 Mil. Innovation1 Biotech's Total Assets for the quarter that ended in May. 2023 was $3.86 Mil. Therefore, Innovation1 Biotech's scaled net operating assets (SNOA) for the quarter that ended in Aug. 2023 was -0.84.


Innovation1 Biotech Scaled Net Operating Assets Historical Data

The historical data trend for Innovation1 Biotech's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovation1 Biotech Scaled Net Operating Assets Chart

Innovation1 Biotech Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only 0.10 -7.25 -0.97 17.60 -0.07

Innovation1 Biotech Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.06 0.34 0.34 -0.84

Competitive Comparison of Innovation1 Biotech's Scaled Net Operating Assets

For the Shell Companies subindustry, Innovation1 Biotech's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovation1 Biotech's Scaled Net Operating Assets Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Innovation1 Biotech's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Innovation1 Biotech's Scaled Net Operating Assets falls into.



Innovation1 Biotech Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Innovation1 Biotech's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Aug. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Aug. 2023 )
=(Operating Assets (A: Aug. 2023 )-Operating Liabilities (A: Aug. 2023 ))/Total Assets (A: Aug. 2022 )
=(0.026-3.277)/43.963
=-0.07

where

Operating Assets(A: Aug. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.076 - 0.05
=0.026

Operating Liabilities(A: Aug. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3.506 - 0.219 - 0.01
=3.277

Innovation1 Biotech's Scaled Net Operating Assets (SNOA) for the quarter that ended in Aug. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Aug. 2023 )
=(Operating Assets (Q: Aug. 2023 )-Operating Liabilities (Q: Aug. 2023 ))/Total Assets (Q: May. 2023 )
=(0.026-3.277)/3.857
=-0.84

where

Operating Assets(Q: Aug. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.076 - 0.05
=0.026

Operating Liabilities(Q: Aug. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3.506 - 0.219 - 0.01
=3.277

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovation1 Biotech Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Innovation1 Biotech's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovation1 Biotech (Innovation1 Biotech) Business Description

Traded in Other Exchanges
N/A
Address
40 Wall Street, Suite 2701, New York, NY, USA, 10005
Innovation1 Biotech Inc is a shell company.
Executives
Grays Peak Llc 10 percent owner 8 THE GREEN, STE. A, DOVER DE 19803
Timothy Orr director, 10 percent owner, officer: President 4010 TANAGER LANE, #A, MEAD WA 99021
Darren Long director, 10 percent owner, officer: CEO & Secretary 4010 TANAGER LANE, #A, MEAD WA 99021
Brian Martinho director, 10 percent owner, officer: Treasurer 4010 EAST TANAGER LANE, MEAD WA 99021